Bold Rebrand for Biotech Differentiation

Immunologix was struggling to stand out in a competitive biotech landscape. Their visual identity lacked cohesion across digital and print materials, their website overwhelmed visitors instead of converting them, and they had no professional materials for conferences, investor meetings, or client presentations. As tradeshows resumed post-COVID, they needed a brand that could hold its own in person and online. The deeper issue was strategic: competitors were telling powerful brand stories while Immunologix was hiding behind technical language their audience couldn't connect with.

We started with stakeholder interviews and competitive analysis to understand where Immunologix sat in the market and what made them genuinely different. From there we built a brand identity system grounded in scientific precision and forward momentum — a bold new logo, cohesive visual language, and a verbal identity that translated their innovation into language that resonates with partners, investors, and the scientific community.

We redesigned the website from the ground up using user research to architect the information hierarchy and optimize the user journey, reducing word blocks in favor of icons, animation, and visual storytelling. We produced a full suite of marketing collateral for business development and conference use, built out a LinkedIn presence with custom banners and profile optimization, and created branded social media templates the team could use and maintain internally.

The rebrand gave Immunologix a brand presence that matched the quality of their science. They now stand out visually and strategically from competitors, carry cohesive materials into every business context, and have a website that generates qualified partnership inquiries rather than confusion.